Alx Oncology Holdings Inc (NASDAQ: ALXO) is -55.61% lower on its value in year-to-date trading and has touched a low of $3.94 and a high of $17.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALXO stock was last observed hovering at around $7.66 in the last trading session, with the day’s loss setting it -1.05%.
Currently trading at $6.61, the stock is 0.68% and -33.69% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -13.71% at the moment leaves the stock -42.87% off its SMA200. ALXO registered -4.62% loss for a year compared to 6-month loss of -52.62%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.43% gain in the last 1 month and extending the period to 3 months gives it a -58.89%, and is -14.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.29% over the week and 11.37% over the month.
Alx Oncology Holdings Inc (ALXO) has around 72 employees, a market worth around $344.38M and $0.00M in sales. Distance from 52-week low is 67.95% and -62.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-92.72%).
Alx Oncology Holdings Inc quarterly earnings per share for the current quarter are estimated at -$0.76 with sales reaching –$ over the same period.The EPS is expected to grow by 24.01% this year, but quarterly earnings will post — year-over-year.
The shares outstanding are 49.95M, and float is at 29.79M with Short Float at 18.50%.
Alx Oncology Holdings Inc (ALXO) Insider Activity
The most recent transaction is an insider sale by Pons Jaume, the company’s PRESIDENT & CSO. SEC filings show that Pons Jaume sold 20,000 shares of the company’s common stock on Jul 11 ’24 at a price of $7.90 per share for a total of $0.16 million. Following the sale, the insider now owns 0.59 million shares.
Alx Oncology Holdings Inc disclosed in a document filed with the SEC on Jul 05 ’24 that Pinto Shelly (SVP, FINANCE AND CAO) sold a total of 1,823 shares of the company’s common stock. The trade occurred on Jul 05 ’24 and was made at $5.50 per share for $10025.0. Following the transaction, the insider now directly holds 92113.0 shares of the ALXO stock.
Still, SEC filings show that on Jul 01 ’24, Pons Jaume (PRESIDENT & CSO) disposed off 10,758 shares at an average price of $5.82 for $62599.0. The insider now directly holds 593,447 shares of Alx Oncology Holdings Inc (ALXO).
